Global Emerging Diseases Institute
The next generation of infectious disease care
The Global Emerging Diseases Institute is a true collaboration between Tampa General Hospital and USF Health Morsani College of Medicine. An entire team of physician leaders from TGH and USF Health Morsani College of Medicine support the Institute, from the inpatient clinical care to the outpatient clinics to teaching and research. The new Institute treats patients suffering from COVID-19 and other infectious diseases, conducts cutting-edge research and teaches the next generation of infectious disease physicians.
As a leading academic medical center, Tampa General Hospital and the USF Health Morsani College of Medicine are dedicating valuable resources to mounting an aggressive fight against COVID-19, both in research and patient care. Since March of 2020, the hospital has treated more than 1,400 COVID patients, produced more than 120,000 COVID tests and currently has more than 30 clinical research trials underway.
A pioneer in teaching, research and clinical care, Tampa General Hospital was also the first in Florida to offer monoclonal antibody treatments to COVID-19 patients, and the only hospital in the Tampa Bay area – one of only five hospitals in the state – to receive the first round of the state’s COVID-19 vaccine pilot program.
Leadership and collaboration will be provided by Dr. John Sinnott, TGH’s chief epidemiologist and chair of Internal Medicine at USF Health Morsani College of Medicine. Dr. Kami Kim, director of Infectious Disease and International Medicine at USF Health Morsani College of Medicine, who will oversee the Institute’s future expanded laboratory space for infectious diseases research and education.
This institute provides a greater opportunity for Tampa General, USF Health and private practice physicians to all collaborate on groundbreaking research and clinical trials to include vaccines and other lifesaving medical testing.